InsiderTrades

Form 4 for PRME Prime Medicine, Inc.

Accepted 2024-10-10 00:00:00 ET · period of report 2024-10-08 · accession 0001894562-24-000043 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2024-10-10 2024-10-08 PRME Gottesdiener Keith Michael See Remarks, Dir G - Gift $0.00 0 682.3K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-10-08 G D 226,925 $0.00 50,241 I By Spouse — — (F1) On October 8, 2024, for bona fide estate planning purposes, the Reporting Person's spouse transferred 226,925 shares of Issuer common stock to a family trust for no consideration.
2 Common Common Stock 2024-10-08 G A 226,925 $0.00 682,259 I By Trust — — (F1) On October 8, 2024, for bona fide estate planning purposes, the Reporting Person's spouse transferred 226,925 shares of Issuer common stock to a family trust for no consideration. (F2) Shares held by a trust for which certain of the Reporting Person's family member is a trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.